Beam Therapeutics Inc. (BEAM) vs Vera Therapeutics, Inc. (VERA)

Beam Therapeutics Inc. and Vera Therapeutics, Inc. are both Biotechnology companies. Beam Therapeutics Inc. and Vera Therapeutics, Inc. are of similar size ($2.6B and $2.4B). Vera Therapeutics, Inc. has the higher net margin (0.00% vs −55.5%) and the higher return on invested capital (0.00% vs −1,599.3%). Across the 14 metrics below, Beam Therapeutics Inc. leads on 8 and Vera Therapeutics, Inc. on 6.

Valuation

Metric BEAM VERA Biotechnology median
P/E n/m n/m 7.88
P/S 16.23 n/m 11.47
P/B 2.37 5.76 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 9.48 n/m 10.73
Earnings yield (3.38%) (17.92%) (28.84%)
Free cash flow yield (14.72%) (14.43%) (23.03%)

Profitability

Metric BEAM VERA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (242.27%) 0.00% 0.00%
Net margin (55.45%) 0.00% 0.00%
Free cash flow margin (238.90%) 0.00% 0.00%
Return on equity (8.18%) (91.75%) (57.72%)
Return on assets (6.23%) (72.32%) (49.22%)
Return on invested capital (1,599.30%) 0.00% 0.00%

Growth

Metric BEAM VERA Biotechnology median
Revenue growth (TTM) 158.88% — 5.64%
EPS growth (last fiscal year) 82.31% (69.45%) —
Revenue growth, 5-year CAGR 466.27% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BEAM VERA Biotechnology median
Debt to equity 0.09 0.18 0.00
Current ratio 14.57 10.92 4.73
Net debt to EBITDA 3.30 2.00 0.96

Dividend

Metric BEAM VERA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BEAM VERA Biotechnology median
Market cap 2.55b 2.40b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack